Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,232.00
(
0.41%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
101.33
(
0.67%
)
Bitcoin
73,040.62
(
-1.22%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

TastyTheElf

Send PM Follow Ignore
Followers 75
Posts 7701
Boards Moderated 0
Alias Born 05/01/2011

TastyTheElf

Re: DewDiligence post# 127064

Wednesday, 09/21/2011 9:34:45 PM

Wednesday, September 21, 2011 9:34:45 PM

Post# of 257253
what makes the MNTA-Amphastar case unusual is that one generic-drug company is suing another.

OK, here comes another naive question... how can there be a patent enfringement in a generics case? What can a company do to infringe on patents when patent protection on the original drug has expired?

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now